文献速递显微修复重建

勃起功能障碍的非手术与手术新技术:系统综述

Emerging nonsurgical and surgical techniques to treat erectile dysfunction: A systematic review of treatment options and published outcomes.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-12-26

该系统综述纳入19篇文献,涵盖3种微创方法和7种新手术技术;显微外科治疗(MABS和海绵体神经移植重建)在神经性或血管性ED患者中显示高成功率,BoNT-A和ADSC治疗在大鼠模型中显示前景,BoNT-A已进入II期临床试验。

要点

  • 显微血管动脉旁路阴茎血运重建术和海绵体神经移植重建在神经性或血管性ED中成功率高。
  • 神经移植方式包括端侧髂腹股沟神经、生殖股神经和腓肠神经移植,均显示高成功率。
  • BoNT-A和ADSC治疗在大鼠模型中显示前景,BoNT-A已进入II期人体临床试验。

核心结论

  • 显微外科干预在神经性或血管性ED患者中显示高成功率,显微外科医生在ED治疗中具有独特价值。

研究设计与样本

  • 系统综述纳入19篇文献,涵盖3种微创方法和7种新手术技术。

主要发现

  • 显微血管动脉旁路阴茎血运重建术和海绵体神经移植重建显示支持证据。
  • 神经移植采用端侧髂腹股沟、生殖股和腓肠神经移植,均显示高成功率。
  • BoNT-A和ADSC治疗在大鼠模型中显示极大前景,BoNT-A今年进入II期人体临床试验。

临床怎么用

  • 对神经性或血管性ED患者可考虑显微外科治疗如MABS或海绵体神经移植重建。

局限性

  • 许多患者对非手术治疗反应不佳,但选择手术干预者较少,可能与手术难度及历史成功率较低有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Erectile dysfunction (ED) is one of the most common causes of morbidity in male patients, with a prevalence of 50-60% in men aged 40-70 years. EDs may be caused by physical or psychological trauma, the former of which may be treatable through surgical intervention. Physical trauma may be further categorized as vasculogenic, neurogenic, or idiopathic in nature. Although many patients do not respond well to nonsurgical treatment options, few opt for surgical intervention. This is likely due to the difficulty of the procedures, as well as relatively low historical success rates. As such, a systematic review of the literature was performed to identify novel surgical interventions for ED. A total of 19 manuscripts were included in this review, representing data of three minimally invasive approaches to ED treatment and seven novel surgical techniques. The data revealed compelling evidence in support of microsurgical treatments for ED - namely, microvascular arterial bypass penile revascularization surgery (MABS) and cavernous nerve graft reconstruction. Nerve grafts varied, with the use of end-to-side ilioinguinal, genitofemoral, and sural grafts, all demonstrating high rates of success. Furthermore, minimally invasive botulinum toxin (BoNT-A) treatment and adipose-derived stem cell (ADSC) therapy have shown extreme promise in rat models; with BoNT-A treatment entering phase II human clinical trials this year. Many of the surgical methods investigated in this review are microsurgical interventions that demonstrate high rates of success in patients with neurogenic or vasculogenic ED. As such, microsurgeons are uniquely trained and positioned to be of value to ED treatment.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Shauly O, Gould DJ, Patel KM, et al. Emerging nonsurgical and surgical techniques to treat erectile dysfunction: A systematic review of treatment options and published outcomes. J Plast Reconstr Aesthet Surg. 2018. PMID: 30765240. doi:10.1016/j.bjps.2018.12.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。